HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
Vol 21, No. 11, November 2017   |   Issue PDF view/purchase
INSIDE INDUSTRY
Breakthrough noodle formula with low-glycemic score of 38
Holista and Holista Foods low-glycemic noodles to secure first order before end of 2017.

Food ingredient specialist, Holista announced that it has developed a breakthrough noodle formula certified to have a low Glycemic Index (GI) - opening a major market for a healthier version of the staple which is vital in the global fight against diabetes and obesity.

The noodles developed by Holista Foods, recorded a GI reading of 38 in independent tests conducted by Glycemic Index Laboratories Inc in Toronto, Canada. The global average GI reading for noodles is 60.

The GI reading indicates the rate in which foods containing carbohydrates raise blood sugar levels in humans, with a lower score indicating healthier food. More than 100 million adult Americans suffer from diabetes or prediabetes, according to the Center for Disease Control and Prevention. 11 million Canadians are living with the disease.

In addition to the low GI reading of 38, each 85 gram serving of noodles contains 11 grams of protein, three grams of fibre, zero sugar, low sodium, low cholesterol and clean label ingredients (no artificial ingredients or preservatives) and cooks in just three minutes.

The availability of low-GI noodles will provide consumers with a healthier option that does not compromise the taste and texture of the product. According to the Economist Intelligence Unit report on "Tackling obesity in ASEAN (South-East Asian Nations)", a low-GI diet was found to be the most effective among food-based interventions.

Holista, a research-driven biotechnology and food ingredients company with operations in Australia and Malaysia, said it expects to conclude the first order for its low-GI noodles by November 2017.

Source: Holista CollTech Ltd / Holista Foods Inc.

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy